Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35126 - 35150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dinitrochlorobenzene	Investigational	PAICS	10606	downregulated	Dinitrochlorobenzene results in decreased expression of PAICS mRNA	4q12	A22388
Dinitrochlorobenzene	Investigational	PDE4B	5142	upregulated	Dinitrochlorobenzene results in increased expression of PDE4B mRNA	1p31.3	A22388
Dinitrochlorobenzene	Investigational	PDE4D	5144	upregulated	Dinitrochlorobenzene results in increased expression of PDE4D mRNA	5q11.2-q12.1	A22388
Dinitrochlorobenzene	Investigational	PGD	5226	upregulated	Dinitrochlorobenzene results in increased expression of PGD mRNA	1p36.22	A21074
Dinitrochlorobenzene	Investigational	PHLDA1	22822	upregulated	Dinitrochlorobenzene results in increased expression of PHLDA1 mRNA	12q15	A22388
Dinitrochlorobenzene	Investigational	PICALM	8301	upregulated	Dinitrochlorobenzene results in increased expression of PICALM mRNA	11q14.2	A22388
Dinitrochlorobenzene	Investigational	PIR	8544	upregulated	Dinitrochlorobenzene results in increased expression of PIR mRNA	Xp22.2	A22389
Dinitrochlorobenzene	Investigational	PLAT	5327	upregulated	Dinitrochlorobenzene results in increased expression of PLAT mRNA	8p11.21	A22388
Dinitrochlorobenzene	Investigational	PLIN2	123	upregulated	Dinitrochlorobenzene results in increased expression of PLIN2 mRNA	9p22.1	A22389
Dinitrochlorobenzene	Investigational	PMAIP1	5366	upregulated	Dinitrochlorobenzene results in increased expression of PMAIP1 mRNA	18q21.32	A21532
Dinitrochlorobenzene	Investigational	PRDX3	10935	downregulated	Dinitrochlorobenzene results in decreased expression of PRDX3 mRNA	10q26.11	A22388
Dinitrochlorobenzene	Investigational	PSMA5	5686	downregulated	Dinitrochlorobenzene results in decreased expression of PSMA5 mRNA	1p13.3	A22388
Dinitrochlorobenzene	Investigational	PTGER3	5733	downregulated	Dinitrochlorobenzene results in decreased expression of PTGER3 mRNA	1p31.1	A22388
Dinitrochlorobenzene	Investigational	PTGR1	22949	upregulated	Dinitrochlorobenzene results in increased expression of PTGR1 mRNA	9q31.3	A21074
Dinitrochlorobenzene	Investigational	PTGS2	5743	upregulated	Dinitrochlorobenzene results in increased expression of PTGS2 mRNA	1q31.1	A22393 A22391
Dinitrochlorobenzene	Investigational	PYHIN1	149628	downregulated	Dinitrochlorobenzene results in decreased expression of PYHIN1 mRNA	1q23.1	A22388
Dinitrochlorobenzene	Investigational	RAB32	10981	downregulated	Dinitrochlorobenzene results in decreased expression of RAB32 mRNA	6q24.3	A22388
Dinitrochlorobenzene	Investigational	RBM17	84991	downregulated	Dinitrochlorobenzene results in decreased expression of RBM17 mRNA	10p15.1	A22388
Dinitrochlorobenzene	Investigational	RBPJ	3516	downregulated	Dinitrochlorobenzene results in decreased expression of RBPJ mRNA	4p15.2	A22388
Dinitrochlorobenzene	Investigational	RGS1	5996	upregulated	Dinitrochlorobenzene results in increased expression of RGS1 mRNA	1q31.2	A22388
Dinitrochlorobenzene	Investigational	RGS2	5997	upregulated	Dinitrochlorobenzene results in increased expression of RGS2 mRNA	1q31.2	A22391
Dinitrochlorobenzene	Investigational	RHOC	389	upregulated	Dinitrochlorobenzene results in increased expression of RHOC mRNA	1p13.2	A22389
Dinitrochlorobenzene	Investigational	RPL27A	6157	upregulated	Dinitrochlorobenzene results in increased expression of RPL27A mRNA	11p15	A22388
Dinitrochlorobenzene	Investigational	S100A10	6281	upregulated	Dinitrochlorobenzene results in increased expression of S100A10 mRNA	1q21.3	A22389
Dinitrochlorobenzene	Investigational	S100B	6285	downregulated	Dinitrochlorobenzene results in decreased expression of S100B mRNA	21q22.3	A22388

Displaying entries 35126 - 35150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability